Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Girish Hiremath

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
The Journal of Allergy and Clinical Immunology|May 16, 2024
Clinical and molecular correlates of the Index of Severity for Eosinophilic EsophagitisHiroki Sato, Evan S Dellon, Seema S Aceves, et al.
Gastrointestinal Endoscopy|January 8, 2026
ASGE consensus recommendations on the endoscopic management of eosinophilic esophagitis - part 2: disease assessment, monitoring, and pediatric considerationsEvan S Dellon, Gary W Falk, David A Katzka, et al.
The Journal of Allergy and Clinical Immunology|May 23, 2022
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future DirectionsEvan S Dellon, Paneez Khoury, Amanda B Muir, et al.
Gastroenterology|May 23, 2022
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future DirectionsEvan S Dellon, Paneez Khoury, Amanda B Muir, et al.
Therapeutic Advances in Rare Disease|August 17, 2023
Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers' journeyMirna Chehade, Glenn Furuta, Amy Klion, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
The Journal of Allergy and Clinical Immunology|May 16, 2024
Clinical and molecular correlates of the Index of Severity for Eosinophilic EsophagitisHiroki Sato, Evan S Dellon, Seema S Aceves, et al.
Gastrointestinal Endoscopy|January 8, 2026
ASGE consensus recommendations on the endoscopic management of eosinophilic esophagitis - part 2: disease assessment, monitoring, and pediatric considerationsEvan S Dellon, Gary W Falk, David A Katzka, et al.
The Journal of Allergy and Clinical Immunology|May 23, 2022
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future DirectionsEvan S Dellon, Paneez Khoury, Amanda B Muir, et al.
Gastroenterology|May 23, 2022
A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future DirectionsEvan S Dellon, Paneez Khoury, Amanda B Muir, et al.
Therapeutic Advances in Rare Disease|August 17, 2023
Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers' journeyMirna Chehade, Glenn Furuta, Amy Klion, et al.
The Lancet. Gastroenterology & Hepatology|June 24, 2026
Dupilumab versus placebo in adults and adolescents with eosinophilic gastritis (DEGAS): a double-blind, placebo-controlled, phase 2, multicentre, randomised controlled trialNirmala P Gonsalves, Evan S Dellon, Kara L Kliewer, et al.
Pageof 8